Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Sulfatinib

SKU: orb1303189

Description

Sulfatinib (KDR-IN-1, HMPL-012) is a highly selective small molecule inhibitor targeting VEGFR1/2/3, FGFR1, and CSF1R with potent activity in the low nanomolar range. It is a valuable research tool for investigating angiogenesis, tumor microenvironment, and related signaling pathways in both cellular and animal models of cancer and inflammatory diseases.

Research Area

Cardiovascular Research, Pharmacology & Drug Discovery, Signal Transduction

Images & Validation

Key Properties

CAS Number1308672-74-3
MW480.58
Purity>99.99% (May vary between batches)
FormulaC24H28N6O3S
SMILESCN(C)CCNS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4[nH]c(C)cc4c3)n2)c1
TargetVEGFR,Potassium Channel,FGFR
Solubility10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.16 mM);DMSO:55 mg/mL (114.45 mM)

Bioactivity

In Vivo
In animal studies, a single oral dose of Sulfatinib effectively inhibits VEGFR2 phosphorylation stimulated by VEGF in lung tissues of nude mice in an exposure-dependent manner. Additionally, a rise in FGF23 plasma levels 24 hours after dosing indicates a suppression of FGFR signaling. Sulfatinib exhibits strong antitumor efficacy across various human xenograft models and significantly reduces CD31 expression, which evidences its potent antiangiogenic effects via the inhibition of VEGFR and FGFR signaling pathways. In the CT-26 syngeneic murine colon cancer model, Sulfatinib achieves moderate tumor growth inhibition following monotherapy. Moreover, after a 10 mg/kg oral dose, the AUC and C_max in mice are 397 ng/mL and 138 ng/mL, respectively .
In Vitro
Sulfatinib inhibits VEGFR1, 2, and 3, FGFR1 and CSF1R kinases with IC 50 s in a range of 1 to 24 nM. Sulfatinib strongly blocks VEGF induced VEGFR2 phosphorylation in HEK293KDR cells and CSF1 stimulated CSF1R phosphorylation in RAW264.7 cells with IC 50 of 2 and 79 nM, respectively. Sulfatinib also attenuates VEGF or FGF stimulated HUVEC cells proliferation with IC 50 < 50 nM . Also, it is a hERG inhibitor with IC 50 of 6.8 μM in CHO cell .

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

KDR-IN-1, KDR, FGFR1, hERG, Sulfatinib

Similar Products

  • Sulfatinib [orb1223225]

    >98% (HPLC)

    1816307-67-1

    480.59

    C24H28N6O3S

    2 mg, 5 mg, 10 mg, 200 mg, 500 mg, 1 g, 25 mg, 100 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

1 mg
$ 80.00
5 mg
$ 120.00
1 ml x 10 mM (in DMSO)
$ 120.00
10 mg
$ 140.00
25 mg
$ 200.00
50 mg
$ 280.00
100 mg
$ 420.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry